Hutin Alice, Levy Yaël, Lidouren Fanny, Kohlhauer Matthias, Carli Pierre, Ghaleh Bijan, Lamhaut Lionel, Tissier Renaud
Univ Paris Est Créteil, INSERM, IMRB, 94010, Créteil, France.
Ecole Nationale Vétérinaire D'Alfort, IMRB, AfterROSC Network, 7 avenue du Général de Gaulle, 94700, Maisons-Alfort, France.
Ann Intensive Care. 2021 May 17;11(1):81. doi: 10.1186/s13613-021-00871-z.
The administration of epinephrine in the management of non-traumatic cardiac arrest remains recommended despite controversial effects on neurologic outcome. The use of resuscitative endovascular balloon occlusion of the aorta (REBOA) could be an interesting alternative. The aim of this study was to compare the effects of these 2 strategies on return of spontaneous circulation (ROSC) and cerebral hemodynamics during cardiopulmonary resuscitation (CPR) in a swine model of non-traumatic cardiac arrest.
Anesthetized pigs were instrumented and submitted to ventricular fibrillation. After 4 min of no-flow and 18 min of basic life support (BLS) using a mechanical CPR device, animals were randomly submitted to either REBOA or epinephrine administration before defibrillation attempts. Six animals were included in each experimental group (Epinephrine or REBOA). Hemodynamic parameters were similar in both groups during BLS, i.e., before randomization. After epinephrine administration or REBOA, mean arterial pressure, coronary and cerebral perfusion pressures similarly increased in both groups. However, carotid blood flow (CBF) and cerebral regional oxygenation saturation were significantly higher with REBOA as compared to epinephrine administration (+ 125% and + 40%, respectively). ROSC was obtained in 5 animals in both groups. After resuscitation, CBF remained lower in the epinephrine group as compared to REBOA, but it did not achieve statistical significance.
During CPR, REBOA is as efficient as epinephrine to facilitate ROSC. Unlike epinephrine, REBOA transitorily increases cerebral blood flow and could avoid its cerebral detrimental effects during CPR. These experimental findings suggest that the use of REBOA could be beneficial in the treatment of non-traumatic cardiac arrest.
尽管肾上腺素对神经学预后的影响存在争议,但在非创伤性心脏骤停的管理中仍推荐使用。主动脉复苏性血管内球囊阻断术(REBOA)可能是一种有趣的替代方法。本研究的目的是在非创伤性心脏骤停的猪模型中比较这两种策略对心肺复苏(CPR)期间自主循环恢复(ROSC)和脑血流动力学的影响。
对麻醉的猪进行仪器植入并使其发生室颤。在无血流4分钟和使用机械CPR设备进行18分钟基础生命支持(BLS)后,在除颤尝试前,动物被随机分为接受REBOA或肾上腺素给药。每个实验组(肾上腺素组或REBOA组)纳入6只动物。在BLS期间,即随机分组前,两组的血流动力学参数相似。给予肾上腺素或REBOA后,两组的平均动脉压、冠状动脉灌注压和脑灌注压均同样升高。然而,与给予肾上腺素相比,REBOA组的颈动脉血流量(CBF)和脑局部氧饱和度显著更高(分别增加125%和40%)。两组均有5只动物实现了ROSC。复苏后,肾上腺素组的CBF仍低于REBOA组,但未达到统计学显著性。
在CPR期间,REBOA促进ROSC的效果与肾上腺素相同。与肾上腺素不同,REBOA可短暂增加脑血流量,并可避免其在CPR期间对脑的有害影响。这些实验结果表明,使用REBOA可能对非创伤性心脏骤停的治疗有益。